Sort
21,281 grants matching “influenza”
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$615,182Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Defining the four major routes of MHC class II antigen processing and presentation with influenza antigens
$614,983Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2024 · AI
THE VAGINAL MICROBIOME, MATERNAL RESPONSE, AND PRETERM BIRTH
$614,963Kristine M. Wylie · Washington University · R01 · FY2022 · HD
Elucidating the roles of alveolar macrophage inflammation and self renewal during influenza infection
$614,905Jie Sun · University Of Virginia · R01 · FY2025 · AG
Angiopoietin/Tie signaling regulation of vascular leakage in lung inflammation
$614,885Donald M McDonald · University Of California, San Francisco · R01 · FY2018 · HL
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury
$614,883Eva Nozik Grayck · University Of Colorado Denver · R01 · FY2016 · HL
Systems Immunogenetics of Flavivirus infection in the Collaborative Cross
$614,878Michael J Gale · Univ Of North Carolina Chapel Hill · U19 · FY2019 · AI
Systems Immunogenetics of Flavivirus infection in the Collaborative Cross
$614,876Michael J Gale · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI
Structural Biology of Influenza Epitopes
$614,755Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
B and Tfh cell dynamics underlying durable antibody responses to flu vaccine in children
$614,745Harinder Singh · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · AI
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases
$614,732Maria Ioana Danila · University Of Alabama At Birmingham · R01 · FY2025 · MD
C-di-AMP signaling in S. aureus
$614,636Joshua Woodward · University Of Washington · R01 · FY2019 · AI
Impact of versican deficiency on the innate immune response to influenza virus
$614,597Charles Wayne Frevert · University Of Washington · R01 · FY2018 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) clinical site protocols
$614,576Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2020 · AI
Topical adjuvants to enhance the efficacy of influenza vaccines
$614,206Carol O Cowing · Lancell, Llc · R44 · FY2011 · AI
Model Development, Data Analysis, and Simulation for Affinity Maturation
$613,954Thomas B Kepler · Boston University Medical Campus · U19 · FY2015 · AI
MOLECULAR EPIDEMIOLOGY OF PANDEMIC INFLUENZA
$613,728St. Jude Children'S Research Hospital · R01 · FY2000 · AI
Proteomics Core
$613,690Nevan J Krogan · Icahn School Of Medicine At Mount Sinai · U19 · FY2013 · AI
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
$613,686Norbert Pardi · University Of Pennsylvania · R01 · FY2022 · AI
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
$613,686Norbert Pardi · University Of Pennsylvania · R01 · FY2023 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$613,641Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Infectious Diseases/Basic Microbial Pathogenic Mechanisms
$613,577Daniel E Goldberg · Washington University · T32 · FY2011 · AI
Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer
$613,551Humam Kadara · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Eosinophils as Effectors of Antibacterial Immunity in the Lungs
$613,501Amali Samarasinghe · University Of Wisconsin-Madison · R01 · FY2025 · HL
Infectious Diseases/Basic Microbial Pathogenic Mechanisms
$613,480Daniel E Goldberg · Washington University · T32 · FY2010 · AI